European policy makers have increasingly moved from primarily focusing on supply-side
regulation of pharmaceutical costs to offering incentives for providers' prescribing behavior …

Objective To review international policies to control expenditure on pharmaceuticals by
influencing the behaviour of patients and providers and regulating the pharmaceutical …

In the last 20 years, expenditures on pharmaceuticals—as well as total health expenditures—
have grown faster than the gross national product in all European countries. The aim of this …

Objective: To examine the prescribing incentive schemes used by primary care groups
(PCGs); to determine the prescribing indicators used under these schemes; and to assess …

Introduction From 2000 to 2004, primary care organisations (PCOs) in England were legally
required to operate a prescribing incentive scheme for their general practices. A statutory …

Background Financial incentives have been suggested to be effective in increasing the
quality and efficiency of drug prescribing. Concern has been raised in relation to potential …

Abstract Methods Primary care organizations (PCOs) in England are required to run a
prescribing incentive scheme. The average payment received by general practitioners (GPs) …

Background The proportion of total healthcare expenditures spent on drugs has continued to
grow in countries of all income categories. Policy‐makers are under pressure to control …

Focus on profit-generating enterprise in healthcare can create conflicts of interest that
adversely impact prescribing and pricing of medicines. Although a global challenge …

Introduction: The appreciable growth in pharmaceutical expenditure has resulted in multiple
initiatives across Europe to lower generic prices and enhance their utilization. However …